Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 15;17(16):e202200451.
doi: 10.1002/asia.202200451. Epub 2022 Jun 30.

Emerging Approaches for Enabling RNAi Therapeutics

Affiliations
Review

Emerging Approaches for Enabling RNAi Therapeutics

Argha M Mallick et al. Chem Asian J. .

Abstract

RNA interference (RNAi) is a primitive evolutionary mechanism developed to escape incorporation of foreign genetic material. siRNA has been instrumental in achieving the therapeutic potential of RNAi by theoretically silencing any gene of interest in a reversible and sequence-specific manner. Extrinsically administered siRNA generally needs a delivery vehicle to span across different physiological barriers and load into the RISC complex in the cytoplasm in its functional form to show its efficacy. This review discusses the designing principles and examples of different classes of delivery vehicles that have proved to be efficient in RNAi therapeutics. We also briefly discuss the role of RNAi therapeutics in genetic and rare diseases, epigenetic modifications, immunomodulation and combination modality to inch closer in creating a personalized therapy for metastatic cancer. At the end, we present, strategies and look into the opportunities to develop efficient delivery vehicles for RNAi which can be translated into clinics.

Keywords: drug delivery; endosomal escape, lipids; gene silencing; peptides.; polymers; siRNA.

PubMed Disclaimer

References

    1. A. Fire, S. Xu, M. K. Montgomery, S. A. Kostas, S. E. Driver, C. C. Mello, Nature 1998, 391, 806-811.
    1. S. M. Elbashir, J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, T. Tuschl, Nature 2001, 411, 494-498.
    1. A. P. McCaffrey, L. Meuse, T.-T. T. Pham, D. S. Conklin, G. J. Hannon, M. A. Kay, Nature 2002, 418, 38-39.
    1. J.-W. Wei, K. Huang, C. Yang, C.-S. Kang, Oncol. Rep. 2017, 37, 3-9.
    1. T. A. Rand, S. Petersen, F. Du, X. Wang, Cell 2005, 123, 621-629.

Substances

LinkOut - more resources